
Journal of Organic Chemistry p. 2704 - 2713 (1995)
Update date:2022-08-03
Topics:
Marino, Joseph P.
Osterhout, Martin H.
Padwa, Albert
A series of alkenyl- and alkynyl-substituted diazo imides were prepared to demonstrate that the intramolecular cycloaddition across a transient isomuenchnone dipole was a viable approach to the quinoline ring system (rings C and D) of the ergot alkaloids.The diazo imides were synthesized by N-malonylacylation of the appropriate amide followed by exposure to standard diazo transfer conditions.The carbenoid intermediate derived by treatment of the diazo imide with rhodium(II) acetate undergoes ready cyclization onto the neighboring amide carbonyl oxygen to generate an isomuenchnone intermediate.Subsequent 1,3-dipolar cycloaddition across the pendant olefin affords the cycloadduct in high yield.The stereochemical assignment of several of the cycloadducts was deduced by X-ray crystallography.The stereochemical outcome of the reaction is the consequence of an endo cycloaddition of the neighboring ?-bond across the transient isomuenchnone dipole.Exposure of the olefinic cycloadduct to boron trifluoride etherate resulted in exclusive carbon-oxygen bond cleavage producing a transient N-acyliminium ion which undergoes rapid proton loss to afford an enamide derivative.In contrast, exposure of the acetylenic cycloadduct to boron trifluoride etherate resulted in exclusive carbon-nitrogen bond cleavage.The resulting oxonium ion underwent reduction with triethylsilane, producing a dihydrofuran derivative.In the absence of a reducing agent, the alkyne cycloadduct underwent a retro Diels-Alder reaction to give a substituted furan derivative in high yield.The Rh(II) acetate catalyzed reaction of the appropriate diazo imide precursor to lysergic acid resulted in a mixture of the desired dipolar cycloadduct as well as a C-H insertion product.Switching to rhodium(II) perfluorobutyrate as the catalyst significantly enhanced the cycloaddition pathway.The inability to carry out a double-bond isomerization thwarted our efforts to synthesize lysergic acid.
View MoreRizhao Lanxing Chemical Indusrial Co.,Ltd
Contact:86-633-2616708
Address:NO.15 West road Shenglan, Lanshan district, Rizhao City
Lonzeal Pharmaceuticals Co., Ltd.
website:http://www.lonzeal.com
Contact:+86-13381011962
Address:RM 801, Yue MOMA, No. 26 Anningzhuang Rd. Haidian District, Beijing, China
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Global United Biotechnology Inc.
Contact:+86-21-61618568
Address:Room 309, Building 6, NO.135, Jinyu Road, Pudong
Anhui Biochem United Pharmaceutical Co., Ltd.
Contact:0086 551 5167062 / 5228268
Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
Doi:10.1021/jo00113a029
(1995)Doi:10.1016/j.tet.2010.12.018
(2011)Doi:10.1107/S0108270194003124
(1995)Doi:10.1039/c6sc00589f
(2016)Doi:10.1039/c39950001109
(1995)Doi:10.1002/anie.201609468
(2016)